Wei Fu
Impact in
- Oncology top 2%
- Colorectal Cancer Surgical Treatments
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer Research top 5%
Papers in
- Oncology 52
- Colorectal Cancer Surgical Treatments 25
- Cancer Cells and Metastasis 8
- Cancer Immunotherapy and Biomarkers 5
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Xin Zhou (40 shared papers)Ye‐Guang Chen (8 shared papers)Jilian Wang (11 shared papers)Wendong Wang (16 shared papers)Yanpeng Ma (14 shared papers)Bingyan Wang (18 shared papers)Lu Wen (9 shared papers)Fuchou Tang (9 shared papers)
- Journals
- Cancer Letters (4 papers)Medicine (3 papers)Cancer Management and Research (2 papers)Nature Cell Biology (2 papers)Environmental Toxicology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Fu
153 papers receiving 4k citations
Wei Fu's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 957
- Cancer Research 308
- Molecular Biology 1.4k
- Pathology and Forensic Medicine 215
- Pulmonary and Respiratory Medicine 313
Countries citing papers authored by Wei Fu
This map shows the geographic impact of Wei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Fu more than expected).
Fields of papers citing papers by Wei Fu
This network shows the impact of papers produced by Wei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Fu. The network helps show where Wei Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 347 | |
| 2 | 2019 | 299 | |
| 3 | 2018 | 286 | |
| 4 | 2020 | 205 | |
| 5 | Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer Hit paper breakdown → | 2023 | 199 |
| 6 | 2018 | 133 | |
| 7 | 2020 | 132 | |
| 8 | 2016 | 115 | |
| 9 | 2022 | 97 | |
| 10 | 2022 | 76 | |
| 11 | 2012 | 74 | |
| 12 | 2022 | 71 | |
| 13 | 2022 | 67 | |
| 14 | 2001 | 64 | |
| 15 | 2017 | 63 | |
| 16 | 2013 | 62 | |
| 17 | 2020 | 57 | |
| 18 | 2018 | 53 | |
| 19 | 2001 | 52 | |
| 20 | 2015 | 52 |
About Wei Fu
Wei Fu is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 163 papers that have together received 4.1k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (25 papers), Cancer Cells and Metastasis (8 papers), Single-cell and spatial transcriptomics (7 papers), Cancer Genomics and Diagnostics (6 papers), Wnt/β-catenin signaling in development and cancer (6 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). The work is most often cited by research in Oncology (957 citations), Cancer Research (308 citations), Molecular Biology (1.4k citations), Pathology and Forensic Medicine (215 citations) and Pulmonary and Respiratory Medicine (313 citations). Wei Fu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xin Zhou, Ye‐Guang Chen, Jilian Wang, Wendong Wang, Yanpeng Ma, Bingyan Wang, Lu Wen, Fuchou Tang, Ruize Qu and Yalong Wang. Their work appears in journals such as Cancer Letters, Medicine, Cancer Management and Research, Nature Cell Biology and Environmental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.